medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2009, Number 587

<< Back Next >>

Rev Med Cos Cen 2009; 66 (587)

Trastorno por deficit atencional en la niñez

Clinton HM

Language: Spanish
References: 17
Page: 15-20
PDF size: 246.89 Kb.


ABSTRACT

The Attention Deficit Hyperactivity Disorder (ADHD) a chronic condition that becomes perceptible in children in preschool and school years. The main characteristics of ADHD are inattention, hyperactivity and impulsivity that are ageinappropiate. The diagnosis is completely clinical and the treatment must be individualized. It is recommended to be a Multimodal Treatment that is based on a combination of medication, behavioral treatment and support groups.


REFERENCES

  1. American Academy of Pediatrics. Committee on Quality Improvement and Subcommittee on Attention-Deficit/Hyperaciivity Dilorder. Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics. 2000; 105:1158-1170 1. Asociacion Americana de Psiquiatn’a. Manual Diagnostico y Estadi’stico de los Trastornos Mentales DSM-IV TR. Washington, DC: Asociacion Americana de Psiquiatn’a.2002; pg 97-107. i. Bennet F. Stimulant medication for the child with attention deficit hyperactivity disorder. In Morgan AM (ed): Attention-Deficit/Hyperactivity Disorder. Pediatrics CItfdcs of North America. 1999; 6:929.

  2. Biederman J, Milberger S, Faraone S, et al: Family-environment risk factors for ADHD: A test of Rutter’s indicators of adversity. Archives of General Psychiatry. 1995; 52:464-470.

  3. Brazelton TB: Fetal obsen •aliens: Could they relate to another modality, such as touch? In Field TM (ed): Touch in Early Development. Mahwah, NJ, Lawrence Eribaum Associates. 1995, pg 53-65.

  4. Chatfield J. Practice Guidelines: AAP Guideline on Treatment of Children with ADHD. American Family Physician. 2001; 65(4): 726-728

  5. Conners CK, Epstein JN, March JS, et al. Multimodal treatment of ADHD (MTA): an alternative outcome analysis. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;40:159-167

  6. Efron D, Jarman F, Barker M. Side effects of methylphenidate and dextroamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics. 1997;100:662-666

  7. Greenhill L, Pliska S et al. Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults. Journal of the American Academy of Child and Adolescent Psychiatry. 2002; 41: 26-49

  8. Jensen P, Arnold L, Richters J, et al. A 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Archives of General Psychiatry. 1999;56:1073-1086

  9. Mannuzza S, Klein R, Bessler A, Malloy P, LaPudula M. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry. 1998;155:493^98

  10. McDonough-Means S, Cohen M. Rakel: Integrative Medicine, 1st ed., Saunders 2003, An Imprint of Elsevier, pgs 35-52

  11. Meaney MJ, Aitken D, et al: Neonatal handling and the development of the adrenocortical response. In Gunzenhauser N (ed): Advances in Touch: New Implications in Human Development. Skillman, NJ: Johnson & Johnson. 1990:80-89.

  12. Miller A, Lee S, Raina Petal. A Review of Therapies for Attention-Deficit/Hyperactivity Disorder. Ottawa, Ontario: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1998

  13. Pelham WE Jr, Wheeler T, Chronis A. Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol. 1998;27:190-205 I

  14. Perrin J, Stein M et al. Clinical Practice Guideline: Treatment of the School-Aged Child WithAttention-Deficit/Hiperactivity Disorder. Pediatrics. 2001; 108 (4): 1033-1044

  15. Pliszka SR, Greenhill LL, Crismon ML, et al: The Texas Children’s Medication Algorithm Project: Report of the Texas consensus conference panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Journal of American Academy of Child and Adolescent Psychiatry 2000:39:908-19.

  16. Stroke M, Barkley R et al. Attention Deficit Hiperactivity Disorder. National Institutes, of Mental Health. 2003; pgs 1-39

  17. Shafritz Keith, Marchione K et al. The Effects of Methylphenidate on Neural Systems of Attention in Attention Deficit Hiperactivity Disorder. American Journal of Psychiatry. 2004;161: 1990-1997




2020     |     www.medigraphic.com